Björklund T - Search Results

1

Gene therapy for dopamine replacement in Parkinson's disease.

Björklund A, Björklund T, Kirik D. Björklund A, et al. Among authors: bjorklund t. Sci Transl Med. 2009 Oct 14;1(2):2ps2. doi: 10.1126/scitranslmed.3000350. Sci Transl Med. 2009. PMID: 20368161

2

Imaging in cell-based therapy for neurodegenerative diseases.

Kirik D, Breysse N, Björklund T, Besret L, Hantraye P. Kirik D, et al. Among authors: bjorklund t. Eur J Nucl Med Mol Imaging. 2005 Dec;32 Suppl 2:S417-34. doi: 10.1007/s00259-005-1909-6. Eur J Nucl Med Mol Imaging. 2005. PMID: 16267643 Review.

3

Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.

Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, Kirik D. Eslamboli A, et al. Among authors: bjorklund t. Brain. 2007 Mar;130(Pt 3):799-815. doi: 10.1093/brain/awl382. Epub 2007 Feb 15. Brain. 2007. PMID: 17303591

4

Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy.

Carlsson T, Björklund T, Kirik D. Carlsson T, et al. Among authors: bjorklund t. Curr Gene Ther. 2007 Apr;7(2):109-20. doi: 10.2174/156652307780363125. Curr Gene Ther. 2007. PMID: 17430130 Review.

5

In vivo gene delivery for development of mammalian models for Parkinson's disease.

Ulusoy A, Bjorklund T, Hermening S, Kirik D. Ulusoy A, et al. Among authors: bjorklund t. Exp Neurol. 2008 Jan;209(1):89-100. doi: 10.1016/j.expneurol.2007.09.011. Epub 2007 Sep 22. Exp Neurol. 2008. PMID: 18028909 Review.

6

Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D. Lundberg C, et al. Among authors: bjorklund t. Curr Gene Ther. 2008 Dec;8(6):461-73. doi: 10.2174/156652308786847996. Curr Gene Ther. 2008. PMID: 19075629 Review.

7

Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

Leriche L, Björklund T, Breysse N, Besret L, Grégoire MC, Carlsson T, Dollé F, Mandel RJ, Déglon N, Hantraye P, Kirik D. Leriche L, et al. Among authors: bjorklund t. J Neurosci. 2009 Feb 4;29(5):1544-53. doi: 10.1523/JNEUROSCI.4491-08.2009. J Neurosci. 2009. PMID: 19193901 Free PMC article.

8

Scientific rationale for the development of gene therapy strategies for Parkinson's disease.

Björklund T, Kirik D. Björklund T, et al. Biochim Biophys Acta. 2009 Jul;1792(7):703-13. doi: 10.1016/j.bbadis.2009.02.009. Epub 2009 Feb 27. Biochim Biophys Acta. 2009. PMID: 19254760 Free article. Review.

9

Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons.

Ulusoy A, Sahin G, Björklund T, Aebischer P, Kirik D. Ulusoy A, et al. Among authors: bjorklund t. Mol Ther. 2009 Sep;17(9):1574-84. doi: 10.1038/mt.2009.142. Epub 2009 Jul 7. Mol Ther. 2009. PMID: 19584816 Free PMC article.

10

Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.

Björklund T, Hall H, Breysse N, Soneson C, Carlsson T, Mandel RJ, Carta M, Kirik D. Björklund T, et al. J Neurochem. 2009 Oct;111(2):355-67. doi: 10.1111/j.1471-4159.2009.06340.x. Epub 2009 Aug 17. J Neurochem. 2009. PMID: 19686242 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters